Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Mo

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Annals of Vascular Diseases|October 15, 2016
Treatment of Primary Varicose Veins in Japan: Japanese Vein Study XVIIHirono Satokawa, Takashi Yamaki, Hirohide Iwata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 21, 2021
Clinical Features of Venous Thromboembolism in Patients With Coronavirus Disease 2019 (COVID-19) in Japan - A Case Series StudyYugo Yamashita, Nobuhiro Hara, Masahiro Obana, et al.
BMJ Open|June 24, 2018
Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) studyYasuo Okumura, Ikuo Fukuda, Mashio Nakamura, et al.
Circulation Reports|April 7, 2023
Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism - Subanalysis of the J'xactly StudyMashio Nakamura, Ikuo Fukuda, Norikazu Yamada, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 3, 2025
Short-term outcomes of thrombolysis versus surgical pulmonary embolectomy in patients with high-risk pulmonary embolismKeiichi Ishida, Yuji Nishimoto, Hiroyuki Ohbe, et al.
Annals of Vascular Diseases|October 2, 2023
Prognostication of Patients with Pulmonary Thromboembolism with and without Residual Deep Vein Thrombosis: A Subanalysis of the J'xactly StudyNorikazu Yamada, Ikuo Fukuda, Mashio Nakamura, et al.
Circulation Reports|August 29, 2022
Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism - Insights From the J'xactly StudyTakeshi Yamashita, Ikuo Fukuda, Mashio Nakamura, et al.
Phlebology|November 26, 2022
Effectiveness and safety of the direct oral anticoagulant in acute distal deep vein thrombosis: From the prospective multicenter observational study, J'xactly, in JapanMakoto Mo, Ikuo Fukuda, Mashio Nakamura, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 26, 2026
Reply: Strengthening causal inference in the comparative evaluation of surgical embolectomy and thrombolysis for high-risk pulmonary embolismKeiichi Ishida, Yuji Nishimoto, Hiroyuki Ohbe, et al.
Cardiovascular Intervention and Therapeutics|December 31, 2024
Effect of balloon pulmonary angioplasty on chronic thromboembolic pulmonary hypertension: an assessment of the learning curve in a Japanese university hospitalNaohiro Komura, Teruyasu Sugano, Fumiaki Ono, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Annals of Vascular Diseases|October 15, 2016
Treatment of Primary Varicose Veins in Japan: Japanese Vein Study XVIIHirono Satokawa, Takashi Yamaki, Hirohide Iwata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 21, 2021
Clinical Features of Venous Thromboembolism in Patients With Coronavirus Disease 2019 (COVID-19) in Japan - A Case Series StudyYugo Yamashita, Nobuhiro Hara, Masahiro Obana, et al.
BMJ Open|June 24, 2018
Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) studyYasuo Okumura, Ikuo Fukuda, Mashio Nakamura, et al.
Circulation Reports|April 7, 2023
Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism - Subanalysis of the J'xactly StudyMashio Nakamura, Ikuo Fukuda, Norikazu Yamada, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 3, 2025
Short-term outcomes of thrombolysis versus surgical pulmonary embolectomy in patients with high-risk pulmonary embolismKeiichi Ishida, Yuji Nishimoto, Hiroyuki Ohbe, et al.
Annals of Vascular Diseases|October 2, 2023
Prognostication of Patients with Pulmonary Thromboembolism with and without Residual Deep Vein Thrombosis: A Subanalysis of the J'xactly StudyNorikazu Yamada, Ikuo Fukuda, Mashio Nakamura, et al.
Circulation Reports|August 29, 2022
Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism - Insights From the J'xactly StudyTakeshi Yamashita, Ikuo Fukuda, Mashio Nakamura, et al.
Phlebology|November 26, 2022
Effectiveness and safety of the direct oral anticoagulant in acute distal deep vein thrombosis: From the prospective multicenter observational study, J'xactly, in JapanMakoto Mo, Ikuo Fukuda, Mashio Nakamura, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 26, 2026
Reply: Strengthening causal inference in the comparative evaluation of surgical embolectomy and thrombolysis for high-risk pulmonary embolismKeiichi Ishida, Yuji Nishimoto, Hiroyuki Ohbe, et al.
Cardiovascular Intervention and Therapeutics|December 31, 2024
Effect of balloon pulmonary angioplasty on chronic thromboembolic pulmonary hypertension: an assessment of the learning curve in a Japanese university hospitalNaohiro Komura, Teruyasu Sugano, Fumiaki Ono, et al.
Pageof 7